98 results
Page 4 of 5
424B5
i5yzsxorkpsaxe
17 Apr 20
Prospectus supplement for primary offering
4:02pm
8-K
EX-1.1
hpj5p
17 Apr 20
Entry into a Material Definitive Agreement
6:06am
424B5
j6td2 u5vb4iy5m
15 Apr 20
Prospectus supplement for primary offering
4:14pm
8-K
EX-10.1
d8mtngoq4 fdc
27 Mar 20
Entry into a Material Definitive Agreement
5:20pm
424B5
j7sbu3ur
27 Mar 20
Prospectus supplement for primary offering
5:19pm
10-K
EX-10.24
uj0yvrol8g64a
16 Mar 20
Annual report
11:09am
10-K
20iyqy6y7pum2g
16 Mar 20
Annual report
11:09am
10-K
EX-10.1
3zyk8fb0t msdigkc8k
16 Mar 20
Annual report
11:09am
DEF 14A
bobfp1v 8oqm2p0a
1 Oct 19
Definitive proxy
6:07am
8-K
EX-10.1
72wtbry8h7yo 0wg
27 Sep 19
Arcturus Therapeutics Announces $9.8 Million Registered Direct Offering of Common Stock
4:25pm
424B5
18p4rtnh
27 Sep 19
Prospectus supplement for primary offering
4:14pm
8-K
qpey5x9spujty ibsxh
23 Sep 19
Arcturus Therapeutics Announces Appointment of Dr. Edward Holmes M.D. andRe-Appointment of Andy Sassine to the Board of Directors
4:34pm
8-K
EX-10.1
l8gvct1t kddrbw97
5 Aug 19
Arcturus Therapeutics Announces $2.3 Million Additional Registered Direct Offering of Common Stock
9:14am
424B5
x1vl1ams
5 Aug 19
Prospectus supplement for primary offering
9:08am